These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3114414)

  • 1. The single-dose bioavailability of different lithium carbonate products.
    Tsang HY; Chen CC; Wen JK
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):543-8. PubMed ID: 3114414
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
    Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
    J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antacid on the bioavailabiity of lithium carbonate.
    Goode DL; Newton DW; Ueda CT; Wilson JE; Wulf BG; Kafonek D
    Clin Pharm; 1984; 3(3):284-7. PubMed ID: 6428800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose bioavailability of two extended-release lithium carbonate products.
    Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
    Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lithium preparations in patients.
    Johnson GF; Hunt GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and safety of a priori lithium loading.
    Kook KA; Stimmel GL; Wilkins JN; Spangher GG
    J Clin Psychiatry; 1985 Feb; 46(2):49-51. PubMed ID: 3918024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of lithium carbonate: single versus multiple daily dosing.
    Bone S; Roose SP; Dunner DL; Fieve RR
    J Clin Psychopharmacol; 1981 Nov; 1(6):390-1. PubMed ID: 6801097
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a slow-release lithium carbonate formulation.
    Cooper TB; Simpson GM; Lee JH; Bergner PE
    Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of the therapeutic dose of lithium carbonate--Polfa on the basis of 24-hour load].
    Rybakowski J
    Pol Tyg Lek; 1984 Mar; 39(12):407-9. PubMed ID: 6433336
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of lithium carbonate: in vivo comparison of two products.
    Meinhold JM; Spunt AL; Trirath C
    J Clin Pharmacol; 1979; 19(11-12):701-3. PubMed ID: 536466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
    Panteleeva GP; Mikhaĭlova NM; Beliaev BS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two lithium carbonate formulations.
    Foster TS; Crass RE; Bustrack JA; Smith RB; Munson JW
    Am J Hosp Pharm; 1980 Nov; 37(11):1528-31. PubMed ID: 7211858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption & urinary & salivary excretion of lithium after oral administration.
    Doshi BS; Rout SJ; Kulkarni RD
    Indian J Med Res; 1983 Nov; 78():708-12. PubMed ID: 6423533
    [No Abstract]   [Full Text] [Related]  

  • 17. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of dosage schedules for delayed-action lithium carbonate].
    Balon R; Kabesh Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of lithium in the dog.
    Rosenthal RC; Koritz GD; Davis LE
    J Vet Pharmacol Ther; 1986 Mar; 9(1):81-7. PubMed ID: 3009841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
    Caldwell HC; Westlake WJ; Connor SM; Flanagan T
    J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.